Generating Rho-0 Cells Using Mesenchymal Stem Cell Lines
Open Access
- 20 October 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (10) , e0164199
Abstract
The generation of Rho-0 cells requires the use of an immortalization process, or tumor cell selection, followed by culture in the presence of ethidium bromide (EtBr), incurring the drawbacks its use entails. The purpose of this work was to generate Rho-0 cells using human mesenchymal stem cells (hMSCs) with reagents having the ability to remove mitochondrial DNA (mtDNA) more safely than by using EtBr. Two immortalized hMSC lines (3a6 and KP) were used; 143B.TK-Rho-0 cells were used as reference control. For generation of Rho-0 hMSCs, cells were cultured in medium supplemented with each tested reagent. Total DNA was isolated and mtDNA content was measured by real-time polymerase chain reaction (PCR). Phenotypic characterization and gene expression assays were performed to determine whether 3a6 Rho-0 hMSCs maintain the same stem properties as untreated 3a6 hMSCs. To evaluate whether 3a6 Rho-0 hMSCs had a phenotype similar to that of 143B.TK-Rho-0 cells, in terms of reactive oxygen species (ROS) production, apoptotic levels and mitochondrial membrane potential (Δψm) were measured by flow cytometry and mitochondrial respiration was evaluated using a SeaHorse XFp Extracellular Flux Analyzer. The differentiation capacity of 3a6 and 3a6 Rho-0 hMSCs was evaluated using real-time PCR, comparing the relative expression of genes involved in osteogenesis, adipogenesis and chondrogenesis. The results showed the capacity of the 3a6 cell line to deplete its mtDNA and to survive in culture with uridine. Of all tested drugs, Stavudine (dt4) was the most effective in producing 3a6-Rho cells. The data indicate that hMSC Rho-0 cells continue to express the characteristic MSC cell surface receptor pattern. Phenotypic characterization showed that 3a6 Rho-0 cells resembled 143B.TK-Rho-0 cells, indicating that hMSC Rho-0 cells are Rho-0 cells. While the adipogenic capability was higher in 3a6 Rho-0 cells than in 3a6 cells, the osteogenic and chondrogenic capacities were lower. Among the drugs and conditions tested, the use of d4t was the best option for producing Rho-0 cells from hMSCs. Rho-0 cells are useful for studying the role of mitochondria in hMSC differentiation.Keywords
Funding Information
- Instituto de Salud Carlos III (FIS-PI12-329)
This publication has 75 references indexed in Scilit:
- Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cellsBMC Medicine, 2013
- Metabolic Plasticity in Stem Cell Homeostasis and DifferentiationCell Stem Cell, 2012
- Epigenetics, epidemiology and mitochondrial DNA diseasesInternational Journal of Epidemiology, 2012
- DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondriaProceedings of the National Academy of Sciences, 2011
- Mitochondrial dysfunction in human breast cancer cells and their transmitochondrial cybridsBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's diseaseDNA Repair, 2009
- Impact of Nucleoside Reverse Transcriptase Inhibitors on Mitochondrial DNA and RNA in Human Skeletal Muscle CellsAntimicrobial Agents and Chemotherapy, 2008
- Generation of ρ 0 cells utilizing a mitochondrially targeted restriction endonuclease and comparative analysesNucleic Acids Research, 2008
- The ERCC1/XPF endonuclease is required for efficient single-strand annealing and gene conversion in mammalian cellsNucleic Acids Research, 2007
- Absence of a Universal Mechanism of Mitochondrial Toxicity by Nucleoside AnalogsAntimicrobial Agents and Chemotherapy, 2007